NCT02660242 - The Use of Mini-dose Glucagon to Prevent Exercise-induced Hypoglycemia in Type 1 Diabetes | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

February 15, 2017

Study Completion Date

February 15, 2017

Conditions

Diabetes Mellitus, Type 1

Interventions

DRUG

G-Pen Mini™ (glucagon injection)

Glucagon (150 µg) 5 minutes before the start of exercise (SQ-abdomen).

OTHER

Glucose Tabs

Dextrose tabs orally (20 grams) 5 minutes before the start of exercise and at 30 minutes of exercise (total 40 grams).

OTHER

Basal Insulin Reduction

Basal insulin reduction to 50% 5 minutes before the start of exercise.

Trial Locations (2)

University of Pennsylvania, Philadelphia

Joslin Diabetes Center, Boston